Product Information
PREDNISOLONE AC 1% EYE DROP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $4.8273 per ML under NDC 70748033202. Its NADAC has been published 83 times since Mar 5, 2025.
FDA first approved this application on Aug 2, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748033202
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PREDNISOLONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA216935FDA Approved
8/2/2024
TE Code
AB
On Market Since
10/11/2024
Pharmacological Classes
Price Statistics
The NADAC for PREDNISOLONE AC 1% EYE DROP has been published 83 times since Mar 5, 2025, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8273 per ML |
|---|---|
| All-time high | $5.3436 (Apr 16, 2025) |
| All-time low | $4.3349 (Nov 19, 2025) |
| 52-week high | $4.8273 |
| 52-week low | $4.3349 |
| Median price | $4.7140 |
| Average price | $4.7169 |
| Largest weekly change | -5.6% (Sep 17, 2025) |
| Weeks tracked | 83 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
prednisolone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREDNISOLONE AC 1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for PREDNISOLONE AC 1% EYE DROP, manufactured by Lupin Pharmaceuticals Inc., is $4.8273 per ML (NDC 70748033202), effective Sep 30, 2026.
How has the price of PREDNISOLONE AC 1% EYE DROP changed over time?
Over the history we have for it, the NADAC for PREDNISOLONE AC 1% EYE DROP has declined 7.5%. It has been tracked across 83 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for PREDNISOLONE AC 1% EYE DROP?
Since Mar 5, 2025, the NADAC for PREDNISOLONE AC 1% EYE DROP has ranged from a low of $4.3349 (Nov 19, 2025) to a high of $5.3436 (Apr 16, 2025), with a median of $4.7140 per ML.
Are there cheaper alternatives to PREDNISOLONE AC 1% EYE DROP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREDNISOLONE AC 1% EYE DROP, is $4.4557 per ML — about 8% below PREDNISOLONE AC 1% EYE DROP.
Who manufactures PREDNISOLONE AC 1% EYE DROP?
PREDNISOLONE AC 1% EYE DROP (NDC 70748033202) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.